NVP-1203 clinical trials
Also written NVP-1203.
How each study uses NVP-1203 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses NVP-1203 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back PainCompletedPhase 3NVP HealthcareNCT04082975Written as NVP-1203
- Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2CompletedPhase 1NVP HealthcareNCT04181437Written as NVP-1203-R1
- Efficacy and Safety of NVP-1203 in Patients With Acute Low Back PainCompletedPhase 2NVP HealthcareNCT03341832Written as NVP-1203
- Study to Compare Pharmacokinetic Characteristics of Eperisone and Aceclofenac With NVP-1203WithdrawnPhase 1NVP HealthcareNCT02289274Written as NVP-1203
- A Study to Evaluate the Food Effect on the Pharmacokinetics of NVP-1203CompletedPhase 1NVP HealthcareNCT02289404Written as NVP-1203